SHANGHAI, Oct. 28, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, today announced that Australian regulatory authorities have...
from PR Newswire: https://ift.tt/3mBlGBn
No comments:
Post a Comment